Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor.
Despite decades of research in the epidermal growth factor receptor (EGFR) signalling field, and many targeted anti-cancer drugs that have been tested clinically, the success rate for these agents in the clinic is low, particularly in terms of the improvement of overall survival. Intratumoral hetero...
Prif Awduron: | Weitsman, G, Mitchell, NJ, Evans, R, Cheung, A, Kalber, TL, Bofinger, R, Fruhwirth, GO, Keppler, M, Wright, ZVF, Barber, PR, Gordon, P, de Koning, T, Wulaningsih, W, Vojnovic, B, Ameer-Beg, S, Lythgoe, M, Arnold, JN, Årstad, E, Festy, F, Hailes, HC, Tabor, AB, Ng, T |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2018
|
Eitemau Tebyg
-
Near-infrared light-sensitive liposomes for enhanced plasmid DNA transfection
gan: Wiraja, Christian, et al.
Cyhoeddwyd: (2021) -
Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes.
gan: Graham, S, et al.
Cyhoeddwyd: (2014) -
Effect of phosphorylation on EGFR dimer stability probed by single-molecule dynamics and FRET/FLIM
gan: Coban, O, et al.
Cyhoeddwyd: (2015) -
ALIX regulates tumor-mediated immunosuppression by controlling EGFR activity and PD-L1 presentation
gan: Monypenny, J, et al.
Cyhoeddwyd: (2018) -
Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
gan: Thomas, E, et al.
Cyhoeddwyd: (2019)